M
Matti Marklund
Researcher at Tufts University
Publications - 75
Citations - 2384
Matti Marklund is an academic researcher from Tufts University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 21, co-authored 50 publications receiving 1673 citations. Previous affiliations of Matti Marklund include The George Institute for Global Health & Uppsala University.
Papers
More filters
Journal ArticleDOI
ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies
Liana C Del Gobbo,Fumiaki Imamura,Stella Aslibekyan,Matti Marklund,Jyrki K. Virtanen,Maria Wennberg,Mohammad Yawar Yakoob,Stephanie E. Chiuve,Stephanie E. Chiuve,Luicito dela Cruz,Alexis C. Frazier-Wood,Amanda M. Fretts,Eliseo Guallar,Chisa Matsumoto,Chisa Matsumoto,Kiesha Prem,Tosh Tanaka,Jason H Y Wu,Xia Zhou,Catherine Helmer,Erik Ingelsson,Erik Ingelsson,Jian-Min Yuan,Pascale Barberger-Gateau,Hannia Campos,Paulo H M Chaves,Luc Djoussé,Graham G. Giles,Jose Gómez-Aracena,Allison M. Hodge,Frank B. Hu,Frank B. Hu,Jan-Håkan Jansson,Ingegerd Johansson,Kay-Tee Khaw,Woon-Puay Koh,Rozenn N. Lemaitre,Lars Lind,Robert Luben,Eric B. Rimm,Eric B. Rimm,Ulf Risérus,Cécilia Samieri,Paul W. Franks,Paul W. Franks,Paul W. Franks,David S. Siscovick,Meir J. Stampfer,Meir J. Stampfer,Lyn M. Steffen,Brian T. Steffen,Michael Y. Tsai,Rob M. van Dam,Rob M. van Dam,Sari Voutilainen,Walter C. Willett,Walter C. Willett,Mark Woodward,Mark Woodward,Dariush Mozaffarian +59 more
TL;DR: In this article, the role of omega-3 polyunsaturated fatty acids for primary prevention of coronary heart disease (CHD) remains controversial, and most prior longitudinal studies evaluated self-reported cons
Journal ArticleDOI
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Catherine M. Clase,Juan Jesus Carrero,David H. Ellison,Morgan E. Grams,Brenda R. Hemmelgarn,Meg Jardine,Meg Jardine,Csaba P. Kovesdy,Csaba P. Kovesdy,Gregory A. Kline,Gregor Lindner,Gregorio T. Obrador,Biff F. Palmer,Michael Cheung,David C. Wheeler,Wolfgang C. Winkelmayer,Roberto Pecoits-Filho,Gloria Ashuntantang,Stephan J. L. Bakker,George L. Bakris,Sunil Bhandari,Emmanuel A. Burdmann,Katrina L. Campbell,David M. Charytan,Deborah J. Clegg,Lilian Cuppari,David Goldsmith,Stein Hallan,Jiang He,Charles A. Herzog,Melanie P. Hoenig,Ewout J. Hoorn,Jens Leipziger,Amanda K. Leonberg-Yoo,Edgar V. Lerma,Jose Ernesto Lopez-Almaraz,Jolanta Malyszko,Johannes F.E. Mann,Matti Marklund,Alicia A. McDonough,Masahiko Nagahama,Sankar D. Navaneethan,Bertram Pitt,Oleh Pochynyuk,Thyago Proença de Moraes,Zubaid Rafique,Bruce M. Robinson,Simon D. Roger,Patrick Rossignol,Adam J. Singer,Andrew Smyth,Manish M. Sood,Michael Walsh,Matthew R. Weir,Charles S. Wingo +54 more
TL;DR: Conference deliberations on potassium homeostasis in health and disease, guidance for evaluation and management of dyskalemias in the context of kidney diseases, and research priorities in each of the above areas are provided.
ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease
Liana C Del Gobbo,Fumiaki Imamura,Stella Aslibekyan,Matti Marklund,Jyrki K. Virtanen,Maria Wennberg,Mohammad Yawar Yakoob,Stephanie E. Chiuve,Luicito dela Cruz,Alexis C. Frazier-Wood,Amanda M. Fretts,Eliseo Guallar,Chisa Matsumoto,Kiesha Prem,Tosh Tanaka,Jason H Y Wu,Xia Zhou,Catherine Helmer,Erik Ingelsson,Jian-Min Yuan,Pascale Barberger-Gateau,Hannia Campos,Paulo H.M. Chaves,Luc Djoussé,Graham G. Giles,Jose Gómez-Aracena,Allison M. Hodge,Frank B. Hu,Jan-Håkan Jansson,Ingegerd Johansson,Kay-Tee Khaw,Woon-Puay Koh,Rozenn N. Lemaitre,Lars Lind,Robert Luben,Eric B. Rimm,Ulf Risérus,Cécilia Samieri,Paul W. Franks,David S. Siscovick,Meir J. Stampfer,Lyn M. Steffen,Brian T. Steffen,Michael Y. Tsai,Rob M. van Dam,Sari Voutilainen,Walter C. Willett,Mark Woodward,Dariush Mozaffarian +48 more
TL;DR: In continuous (per 1-SD increase) multivariable-adjusted analyses, the ω-3 biomarkers ALA, DPA, and DHA were associated with a lower risk of fatal CHD, with relative risks of 0.91, 0.84, and 0.96, respectively.
Journal ArticleDOI
Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies.
Jason H Y Wu,Matti Marklund,Fumiaki Imamura,Nathan L. Tintle,Andres V Ardisson Korat,Janette de Goede,Xia Zhou,Wei-Sin Yang,Marcia C de Oliveira Otto,Janine Kröger,Waqas Qureshi,Jyrki K. Virtanen,Julie K. Bassett,Alexis C. Frazier-Wood,Maria Lankinen,Rachel A. Murphy,Kalina Rajaobelina,Liana C Del Gobbo,Nita G. Forouhi,Robert Luben,Kay-Tee Khaw,Kay-Tee Khaw,Nicholas J. Wareham,Anya Kalsbeek,Jenna Veenstra,Juhua Luo,Frank B. Hu,Hung-Ju Lin,David S. Siscovick,Heiner Boeing,Tzu-An Chen,Brian T. Steffen,Lyn M. Steffen,Allison M. Hodge,Gudny Eriksdottir,Albert V. Smith,V. Gudnason,Tamara B. Harris,Ingeborg A. Brouwer,Claudine Berr,Catherine Helmer,Cécilia Samieri,Markku Laakso,Michael Y. Tsai,Graham G. Giles,Tarja Nurmi,Lynne E. Wagenknecht,Matthias B. Schulze,Rozenn N. Lemaitre,Kuo-Liong Chien,Sabita S. Soedamah-Muthu,Johanna M. Geleijnse,Qi Sun,William S. Harris,Lars Lind,Johan Ärnlöv,Johan Ärnlöv,Ulf Risérus,Renata Micha,Dariush Mozaffarian +59 more
TL;DR: Findings suggest that linoleic acid has long-term benefits for the prevention of type 2 diabetes and that arachidonic acid is not harmful.
Journal ArticleDOI
Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality: An Individual-Level Pooled Analysis of 30 Cohort Studies
Matti Marklund,Matti Marklund,Jason H Y Wu,Fumiaki Imamura,Liana C Del Gobbo,Amanda M. Fretts,Janette de Goede,Peilin Shi,Nathan L. Tintle,Maria Wennberg,Stella Aslibekyan,Tzu An Chen,Marcia C de Oliveira Otto,Yoichiro Hirakawa,Helle Højmark Eriksen,Janine Kröger,Federica Laguzzi,Maria Lankinen,Rachel A. Murphy,Kiesha Prem,Cécilia Samieri,Jyrki K. Virtanen,Alexis C. Wood,Kerry L. M. Wong,Wei Sin Yang,Xia Zhou,Ana Baylin,J.M.A. Boer,Ingeborg A. Brouwer,Hannia Campos,Paulo H M Chaves,Kuo-Liong Chien,Ulf de Faire,Luc Djoussé,Gudny Eiriksdottir,Naglaa El-Abbadi,Naglaa El-Abbadi,Nita G. Forouhi,J. Michael Gaziano,Johanna M. Geleijnse,Bruna Gigante,Graham G. Giles,Eliseo Guallar,Vilmundur Gudnason,Tamara B. Harris,William S. Harris,Catherine Helmer,Mai Lis Hellénius,Allison M. Hodge,Frank B. Hu,Paul F. Jacques,Paul F. Jacques,Jan-Håkan Jansson,Anya Kalsbeek,Kay-Tee Khaw,Woon-Puay Koh,Markku Laakso,Karin Leander,Hung-Ju Lin,Lars Lind,Robert Luben,Juhua Luo,Barbara McKnight,Jaakko Mursu,Toshiharu Ninomiya,Kim Overvad,Kim Overvad,Bruce M. Psaty,Bruce M. Psaty,Eric B. Rimm,Matthias B. Schulze,David S. Siscovick,Michael S. Nielsen,Albert V. Smith,Brian T. Steffen,Lyn M. Steffen,Qi Sun,Johan Sundström,Michael Y. Tsai,Hugh Tunstall-Pedoe,Matti Uusitupa,Rob M. van Dam,Jenna Veenstra,W. M. Monique Verschuren,Nicholas J. Wareham,Walter C. Willett,Mark Woodward,Mark Woodward,Mark Woodward,Jian-Min Yuan,Renata Micha,Rozenn N. Lemaitre,Dariush Mozaffarian,Ulf Risérus +93 more
TL;DR: In this paper, the authors evaluated how in vivo circulating and tissue levels of linoleic acid (LA) and arachidonic acid (AA) relate to incident cardiovascular disease (CVD) across multiple international studies.